Multicentre Trial Evaluating the Safety and Tolerability of Estetrol-Drospirenone Combined Oral Contraceptive in Postmenarchal Female Adolescents. [PDF]
J Clin MedLindén Hirschberg A +7 more
europepmc +1 more source
Clinical and endocrine effects of pharmacological therapy in endometriosis: a systematic review and meta-analysis. [PDF]
Front Endocrinol (Lausanne)Sun R, Xu H, Ma R, Xu J, Liu Y, Mao D.
europepmc +1 more source
Comparison of Substances in Combined Oral Contraceptives Used in Acne Vulgaris, Hirsutism, Migraine, and Dysmenorrhea. [PDF]
Med Sci MonitWójcikiewicz P +4 more
europepmc +1 more source
Drug-drug interactions between sex hormones and analgesics linked to thromboembolic events: an FDA adverse event reporting system analysis. [PDF]
Front PharmacolYamazaki S, Onda K, Masuyama K.
europepmc +1 more source
Case Report: Menstrual cycle-related psychosis in bipolar I disorder, remitting with a combined oral contraceptive. [PDF]
Front PsychiatryHanyu S, Yoshimoto K, Shimizu N.
europepmc +1 more source
Impact of estetrol and drospirenone combination therapy on alleviation of the pelvic pain of endometriosis: a randomized control trial. [PDF]
F S RepHarada T +6 more
europepmc +1 more source
Predicting venous thromboembolism risk from endogenous thrombin potential-based normalized activated protein C sensitivity ratio assay: toward early assessment of combined oral contraceptives. [PDF]
Res Pract Thromb HaemostMorimont L +4 more
europepmc +1 more source
Contraceptive-Induced Weight Gain-Myth and Reality Review. [PDF]
Life (Basel)Butureanu T +6 more
europepmc +1 more source
Delayed start of estetrol drospirenone versus ethinyl estradiol gestodene for ovulation inhibition in a noninferiority randomized controlled trial. [PDF]
Sci RepIttipuripat S +6 more
europepmc +1 more source
Use of progestin-only drospirenone-based pills in hyperandrogenic women with polycystic ovary syndrome. [PDF]
Arch Gynecol ObstetDiterlizzi A +12 more
europepmc +1 more source